|
|
 |
|
Viewing report
|
|
|
|
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs
Datamonitor, May 2002
In-depth profiles of late stage asthma products, an overview of interesting early phase compounds and forecasted new product sales, , The anti-asthmatic market is well served by existing therapies, such as the beta2-agonists and corticosteroids opinion leaders estimate that 95% of asthma patients can be successfully treated with these agents. Consequently, to attain commercial success, pipeline products need to offer significant advantages over currently marketed therapies, particularly with respect to convenience., , This Analysis provides:, , - evaluation of new compounds in development for asthma and their ability to satisfy the unmet needs of the market , , - identification of opportunities for companies to maximize the market potential of their developmental compounds , , - assessment of the impact of novel compounds on the market positions of anti-asthmatics currently leading the market , , - forecasted sales of the key anti-asthmatics that will be launched over the period 2002 to 2009,
Customers who bought this item also bought
Br Malls Participacoes Sa
Br. Holdings Corporation
The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective
The 2009 Import and Export Market for Butadiene Rubber (BR) in China
The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran
The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus
The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria
The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Slovakia
The 2009 Import and Export Market for Butadiene Rubber (BR) in Turkey
The 2009 Import and Export Market for Butadiene Rubber (BR) in Uruguay
|
|
|
|
